British Journal of Clinical Pharmacology

Aims & Scope

Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters.

The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry.

It also publishes research on new methods, new drugs and new approaches to treatment.

The Journal is recognised as one of the leading publications in its field.

It is online only, publishes open access research through its OnlineOpen programme and is published monthly.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3
2024	3.10

Journal Rank

Year	Value
2024	3794

Journal Citation Indicator

Year	Value
2024	4440

SJR (SCImago Journal Rank)

Year	Value
2024	1.155

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A new taxonomy for describing and defining adherence to medications

  Citation: 1434

  Authors: Bernard, Sabina, Dyfrig A., Kardas, Jenny, Todd, Fabienne, Emily, Valerie, Pawel, Michal, Comfort, Wendy, Jeffrey K., J.

• Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications

  Citation: 1366

  Authors: A. A., S. H. D.

• The two‐period cross‐over clinical trial.

  Citation: 1136

  Authors: M., P.

• Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?

  Citation: 1063

  Authors: Philip C.

• Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

  Citation: 987

  Authors: N. R., M. B.

• Validation and validity of diagnoses in the General Practice Research Database: a systematic review

  Citation: 909

  Authors: Emily, Sara L., W. Marieke, Liam, Andrew J.

• The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

  Citation: 708

  Authors: Joachim, Karin, Hildegard, Dietmar, Willy

• Bioavailability of bioactive food compounds: a challenging journey to bioefficacy

  Citation: 693

  Authors: Maarit J., Mathieu, Cristina, Lucas, Sagar K., Marcia

• Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

  Citation: 646

  Authors: John O., Donald J.

• Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

  Citation: 593

  Authors: Christoph, Jürgen, Steffen, Ivar

---